The strongest predictors of early VAs after LVAD implantation are a pre-implant history of VAs, pre-implant atrial fibrillation, HF lasting over 12 months, and the absence of therapy with ACE inhibitors and beta-blockers [9,25,26,27,28]. This evidence concerns the gene ACE and hydrops fetalis.